dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Julia Cano, Antonio |
dc.contributor.author | Gomez Moruno, Antonio |
dc.contributor.author | Lopez Lasanta, Maria America |
dc.contributor.author | Blanco, Francisco |
dc.contributor.author | Fernandez-Nebro, Antonio |
dc.contributor.author | Li, Tianlu |
dc.contributor.author | Martinez Mateu, Sergio Hilario |
dc.contributor.author | Marsal Barril, Sara |
dc.contributor.author | Moreno Ruzafa, Estefania |
dc.contributor.author | Erra Duran, Alba |
dc.date.accessioned | 2022-09-09T08:18:33Z |
dc.date.available | 2022-09-09T08:18:33Z |
dc.date.issued | 2022-06 |
dc.identifier.citation | Julià A, Gómez A, López-Lasanta M, Blanco F, Erra A, Fernández-Nebro A, et al. Longitudinal analysis of blood DNA methylation identifies mechanisms of response to tumor necrosis factor inhibitor therapy in rheumatoid arthritis. eBioMedicine. 2022 Jun;80:104053. |
dc.identifier.issn | 2352-3964 |
dc.identifier.uri | https://hdl.handle.net/11351/8094 |
dc.description | Epigenètica; Artritis reumatoide; Resposta al tractament |
dc.description.sponsorship | This study was funded by the Instituto de Salud Carlos III. |
dc.language.iso | eng |
dc.publisher | Elsevier |
dc.relation.ispartofseries | eBioMedicine;80 |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Artritis reumatoide - Tractament |
dc.subject | Factor de necrosi tumoral - Inhibidors |
dc.subject | ADN - Metilació |
dc.subject.mesh | Arthritis, Rheumatoid |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | DNA Methylation |
dc.subject.mesh | Antirheumatic Agents |
dc.title | Longitudinal analysis of blood DNA methylation identifies mechanisms of response to tumor necrosis factor inhibitor therapy in rheumatoid arthritis |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1016/j.ebiom.2022.104053 |
dc.subject.decs | artritis reumatoide |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | metilación del ADN |
dc.subject.decs | antirreumáticos |
dc.relation.publishversion | https://doi.org/10.1016/j.ebiom.2022.104053 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Julià A, Gómez A, López-Lasanta M, Li T, Martínez-Mateu SH, Marsal S] Grup de Recerca en Reumatologia, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain. [Blanco F] Rheumatology Department, INIBIC-Hospital Universitario A Coruña, A Coruña, Spain. [Erra A] Grup de Recerca en Reumatologia, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain. Rheumatology Department, Hospital de San Rafael, Barcelona, Spain. [Fernández-Nebro A] Rheumatology Department, Hospital Regional Universitario de Málaga, Málaga, Spain. [Moreno E] Grup de Recerca en Reumatologia, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain. Rheumatology Unit, Consorci Sanitari de l'Alt Penedès, Spain |
dc.identifier.pmid | 35576644 |
dc.identifier.wos | 000805310000009 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |